← Back to Vaccine Database

SII B.1.351 + Matrix-M1 adjuvant

Protein based vaccine · VDDBV0697

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT05029856 Phase 2COVID-19